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Open science practices provide important safeguards that serve to improve the replicability 
and integrity of findings. E-cigarette research is a highly contested domain that would benefit 
from greater adoption of these practices. 
 
As scientists we are supposed to aspire to be seekers of truth, led to whatever conclusions 
the data take us. But in reality we are also human, and therefore subject to the same array 
of biases that apply to everyone, scientists and non-scientists alike (1). This includes a 
tendency to see patterns in our data that may not be there, the inclination to seek out 
evidence that confirms our preconceptions and a tendency to believe what we want to 
believe.  
 
The scientific method protects against this to some extent, but concerns around the 
reproducibility of much published scientific research (2) have led to questions about whether 
the scientific method is being applied sufficiently rigorously. The prioritisation of novel 
“ground-breaking” findings, the emphasis on the data “telling a story”, and the tendency for 
results that conform to the dominant narrative to be more readily published all conspire to 
undermine the robustness of published findings. Incentives to obtain a particular set of 
results, together with biases that encourage us to see what we’re looking for, is a potentially 
damaging combination. Over time there has been a gradual move in biomedical journals to 
include conflict of interest (COI) statements, but these typically focus on financial COIs (and 
are themselves often imperfect and/or incomplete). There has been much less attention paid 
to the potential role of how cognitive and motivational factors shape the interpretation of 
evidence. 
 
These issues are particularly acute in areas where there are strongly held beliefs and 
significant opportunities to produce impactful findings. One such area is e-cigarette 
research. The rapid increase in prevalence of a consumer product containing nicotine, that is 
purported to be much safer than smoking has brought to the fore some deeply held 
differences of opinion about tobacco harm reduction. The research and public health 
community has fractured, with different camps coalescing around different attitudes. The 
result is that we are seeing conclusions being drawn from e-cigarette research that appear 
to be based in many cases on pre-suppositions rather than a dispassionate analysis of the 
evidence and its context. We are also seeing researchers disputing or discounting 
conclusions that go against their view using criteria that they are not applying to conclusions 
that support their view. 
 
For example, some researchers have claimed that correlational evidence convincingly 
demonstrates a causal association between youth e-cigarette use and subsequent smoking 
(3, 4), while others argue that these studies have not adequately dealt with unmeasured 
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confounding (5). Similarly, some researchers use correlational evidence to argue that e-
cigarette use reduces smoking cessation rates (3, 6), while others argue that after taking into 
account selection bias and unmeasured confounding e-cigarette use actually increases 
population cessation rates (7, 8). Some researchers argue that RCT evidence supports the 
effectiveness of e-cigarettes for cessation, while others argue that RCTs showing positive 
effects have limited generalisability (see 9). The same evidence is interpreted very differently 
by different researchers. 
 
Resolving disagreements on these issues cannot be achieved by simply accumulating more 
and more evidence with similar potential for bias and applying similar judgement processes 
to evaluating that evidence. 
 
There is growing interest in approaches that may help mitigate research biases, and provide 
a level of quality control in our research workflows. ‘Open research’ practices, in particular, 
where some or all elements of a research workflow are made publicly-available, is one area 
where there has been a great deal of movement and innovation in recent years. This 
includes pre-registration of study protocols, sharing of study materials, posting of study data, 
and so on. This transparency can improve quality (for example, by requiring good data 
curation as well as increasing the level of checking that takes place before data are made 
public) (10). It can also help to protect against biases that can creep in once data have been 
seen (for example, by requiring clearly specified a priori hypothesis in pre-registered study 
protocols, so that additional analyses conducted after the data have been seen to be 
identified as post-hoc and exploratory). Journals have an important role to play here, for 
example by first having strong policies on protocol registration, data sharing and so on, and 
second by enforcing these policies robustly (11). 
 
Importantly, open research practices can make it easier to fully scrutinise the evidence on 
which claims are based, introduce quality control checks, and protect against biases. In 
doing so, it can reduce the scope for inconsistent application of quality criteria and help to 
increase trust in findings that conform to these practices. Widespread adoption of open 
research practices, in particular pre-registration of study protocols and analysis plans, and 
ensuring data are FAIR (Findable, Accessible, Interoperable, and Reusable), would go some 
way to ensuring that the findings of e-cigarette research are robust and valid. This will 
require clear journal policies that are enforced. A number of initiatives currently being piloted 
may also help ensure we have a robust evidence base to inform policy – adversarial 
replications (12) and Registered Reports funding models (where a single review process 
provides applicants with funding with their work and in-principle acceptance of their results 
irrespective of the eventual outcome) (1). Given the critical importance of understanding the 
epidemiology of vaping, and its possible impacts on tobacco use, together with the strong 
feelings that have built up within the tobacco control and research community, adoption of 
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